Skip to content

Common Stock at other companies

Amgen logo
AmgenAMGN
2.8B0.0%
Incyte logo
IncyteINCY
400M0.0%
Tango Therapeutics logo
Tango TherapeuticsTNGX
400M+100%
CG Oncology logo
CG OncologyCGON
$9K+12.5%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$182K+8.3%
Celcuity logo
CelcuityCELC
95M0.0%

Other financials

Income statement

See full
Operating income-$103.6M-38.3%
Net income-$97.4M-35.2%
EPS (diluted)-$0.53-1.9%

Balance sheet

See full
Cash & equivalents$241.2M+91.4%
Total debt$15.5M-9.4%
Total equity$607.7M+177%
Total assets$903.0M+218%

Cash flow

See full
Operating cash flow-$86.9M-30.6%
CapEx$449.0K-17.9%
Free cash flow-$87.3M-30.2%

Valuation

See full
Market cap$5.9B+816%

Profitability

See full
Operating margin-1,044.3%
Net margin-950.4%
FCF margin-184.7%

Returns & leverage

See full
Return on equity-85.7%+1.7pp
Debt / equity-0.1×
Current ratio15.1×+10.0×

Where this comes from

Reported directly by Cogent Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cogent Biosciences, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cogent Biosciences, Inc.'s common stock?
Cogent Biosciences, Inc. (COGT) reported common stock of $171K in Q1 2026.
How has Cogent Biosciences, Inc.'s common stock changed year-over-year?
Cogent Biosciences, Inc.'s common stock increased by 50.0% year-over-year, from $114K to $171K.
What is the long-term trend for Cogent Biosciences, Inc.'s common stock?
Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s common stock has grown at a 38.1% compound annual growth rate (CAGR), from $32K to $161K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).